Annals of Oncology 13:1246-1251, 2002
© 2002 European Society for Medical Oncology
Original Paper |
Loss of cyclin D1 and p16 expression correlates with local recurrence in nasopharyngeal carcinoma following radiotherapy
Department of 1 Otolaryngology and 2 Pathology, Chang-Gung University, Chang-Gung Memorial Hospital, Kaohsiung; 3 Department of Biological Sciences, National Sun Yan-Sen University, Kaohsiung; 4 Department of Pathology, Veterans General Hospital-Kaohsiung, Kaohsiung, Taiwan, Republic of China
Received 24 September 2001; revised and accepted 11 February 2002
Background:
The cyclin D1/p16/Rb pathway plays a critical role in tumorigenesis and each component of this pathway may be affected in various malignancies. The purpose of this study was to investigate the expression and prognostic significance of these proteins in nasopharyngeal carcinoma (NPC).
Patients and methods:
Sixty-five patients undergoing radiotherapy for NPC were analyzed. The expression of cyclin D1, p16 and pRb was evaluated with immunohistochemical analysis of archived pretreatment tumor materials and expression of these proteins was correlated with clinicopathological parameters.
Results:
Positive expression of cyclin D1 was observed in 43 of 65 NPCs (66%). p16 and pRb inactivation was identified in 42 of 65 (65%) and four of 65 (6%) tumors, respectively. All but seven tumors (58 of 65, 89%) contained at least one alternation in the cyclin D1/p16/Rb pathway. Loss of cyclin D1 as well as p16 was closely related to local recurrence after radiotherapy for NPC (P = 0.015 and 0.047). No association between pRb expression and clinicopathological outcome was apparent.
Conclusions:
The study’s results suggest that the cyclin D1/p16/Rb pathway plays an important role in NPC tumorigenesis. We also find that cyclin D1 and p16 protein levels in NPC may be of use clinically as a predictor of local tumor control.
Key words: cyclin D1, local recurrence, nasopharyngeal carcinoma, p16
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. Zhang, Z. Zeng, Y. Zhou, W. Xiong, S. Fan, L. Xiao, D. Huang, Z. Li, D. Li, M. Wu, et al. Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis Acta Biochim Biophys Sin, May 1, 2009; 41(5): 414 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. L. Cheung, H. L. Lung, S. C. Hung, E. W. L. Law, Y. Cheng, W. L. Yau, D. K. Bangarusamy, L. D. Miller, E. T.-B. Liu, J.-Y. Shao, et al. Functional Analysis of a Cell Cycle-Associated, Tumor-Suppressive Gene, Protein Tyrosine Phosphatase Receptor Type G, in Nasopharyngeal Carcinoma Cancer Res., October 1, 2008; 68(19): 8137 - 8145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Biliran Jr., S. Banerjee, A. Thakur, F. H. Sarkar, A. Bollig, F. Ahmed, J. Wu, Y. Sun, and J. D. Liao c-Myc Induced Chemosensitization Is Mediated by Suppression of Cyclin D1 Expression and Nuclear Factor-{kappa}B Activity in Pancreatic Cancer Cells Clin. Cancer Res., May 1, 2007; 13(9): 2811 - 2821. [Abstract] [Full Text] [PDF]
|
|